ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 65 filers reported holding ACORDA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 14.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $175,000 | +22.4% | 238,741 | +241.1% | 0.00% | +50.0% |
Q4 2019 | $143,000 | -12.3% | 69,994 | +23.3% | 0.00% | -33.3% |
Q3 2019 | $163,000 | -62.6% | 56,779 | +155.8% | 0.00% | -62.5% |
Q3 2018 | $436,000 | -40.2% | 22,200 | -42.8% | 0.01% | +14.3% |
Q4 2016 | $729,000 | +62.7% | 38,784 | +80.8% | 0.01% | +16.7% |
Q3 2016 | $448,000 | -37.7% | 21,456 | -23.9% | 0.01% | -25.0% |
Q2 2016 | $719,000 | +12.9% | 28,208 | +17.1% | 0.01% | -20.0% |
Q1 2016 | $637,000 | +162.1% | 24,080 | +162.9% | 0.01% | +66.7% |
Q3 2015 | $243,000 | -18.7% | 9,160 | +2.0% | 0.01% | -25.0% |
Q1 2015 | $299,000 | -47.4% | 8,977 | -46.5% | 0.01% | -69.2% |
Q3 2014 | $568,000 | – | 16,778 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |